Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden
Tine Iskov Kopp(Frederiksberg Hospital), Lene Dreyer(Gentofte Hospital), Else Helene Ibfelt(Steno Diabetes Centers), Elizabeth V. Arkema(Karolinska Institutet), Johan Askling(Karolinska University Hospital), Henning Locht(Frederiksberg Hospital), Rikke Kart Jacobsen(Frederiksberg Hospital), Dorte Vendelbo Jensen(Gentofte Hospital), Bénédicte Delcoigne(Karolinska Institutet), Finn Sellebjerg(Danish Multiple Sclerosis Center), René Cordtz(Gentofte Hospital), Melinda Magyari(University of Copenhagen)
Cited by 48
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
|Arthritis & Rheumatism|2006|888
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
|Clinical Epidemiology|2021|267